Queen Anne Street Medical Centre is a private independent acute care hospital established in 2005. It is located in the heart of London's medical district adjacent to Harley Street.
Located behind an elegant façade in historic Queen Anne Street in the h
www.chelseaoutpatientcentre.com, 15 July 2013 [cached]
Dr Brian O'Connor, Medical Director, Chelsea Outpatient CentreMedical Director, Dr Brian O'Connor
Dr O'Connor is a leading specialist in the field of Respiratory Medicine and Allergy with many years of senior clinical and healthcare experience.His major clinical interests are asthma, smoking related lung disease, chest infections and general respiratory medicine.
In full time private practice since March 2008, Dr O'Connor remains fully active in clinical research on Airways Diseases.
Dr O'Connor's role as Medical Director encompasses aspects of clinical governance and excellence, as well as providing respiratory outpatient diagnoses and treatment as part of our Respiratory Medicine services.
In private practice since 1996, Dr Brian J O'Connor, Consultant Physician, Respiratory Medicine and Allergy (MD FRCP FRCPI), has been based primarily at Cromwell and Lister Hospitals in London where he saw his private patients part time, whilst continuing to hold his National Health Service responsibilities as a Consultant and Senior Lecturer in Respiratory Medicine.
Dr O'Connor is now in full time private practice and consults across a number of leading private healthcare institutions across London.
Dr Brian O'Connor graduated from Dublin in 1980, completed his post graduate general medical training there and passed the examination for membership of Royal College of Physicians of Ireland in 1984.He moved to Royal Brompton Hospital in 1988 to complete his specialist respiratory training and completed an MD thesis on research into airway inflammation and asthma.He is a Fellow of the Royal College of Physicians of Ireland and of the Royal College of Physicians of London.In 1992 Dr O'Connor was appointed as Senior Lecturer at the National Heart and Lung Institute and a Consultant in Respiratory Medicine at Royal Brompton Hospital in London.
There he established a leading edge clinical research facility, to investigate new treatment strategies in Airways Disease.
In 1997 he relocated to Kings College School of Medicine to continue his clinical research and was appointed Consultant Respiratory Physician at Kings College Hospital until March 2008, when he commenced full time private practice.Dr Brian O'Connor is actively involved with the international respiratory community and is a member of a number of professional organisations overseas and in the UK.He attends regular meetings and international conferences.
This demonstrates his dedication and commitment to his patients as he proactively engages with his Consultant peers to keep abreast with new and exiting discovers and treatment in his chosen field of medicine.
He also shares his wealth of experience and expertise within his community.
His on going commitment to research and development through Respiratory Clinical Trials gives him the platform to publish and present papers in his areas of expertise.
Dr. Brian O'Connor, Consultant Chest Physician at King's College Hospital, London, U.K., and the study's principal investigator said: "These results demonstrate that IPL576,092, administered prior to allergen challenge, can reduce the response to an antigenin an induced asthma setting and underlines the potential for LSAIDs to become a major new oral therapy for asthma."
De Souza said, "Aventis is already a leader in the treatment of asthma and other respiratory diseases and is committed to bringingnew therapies to market.These results from the pilot study with IPL576,092 indicate that LSAIDs may prove to be future drugs of choice in the large global respiratory disease market." Study Design The double-blind, placebo-controlled, randomized, crossover study was designed to compare the relative effects of two doses of IPL576,092 in comparison to placebo.